Coral Laboratories is currently trading at Rs. 64.50, up by 2.95 points or 4.79% from its previous closing of Rs. 61.55 on the BSE.
The scrip opened at Rs. 59.85 and has touched a high and low of Rs. 64.50 and Rs. 59.85 respectively. So far 200 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 83.00 on 08-Jan-2013 and a 52 week low of Rs. 55.00 on 02-May-2013.
Last one week high and low of the scrip stood at Rs. 62.95 and Rs. 60.00 respectively. The current market cap of the company is Rs. 21.38 crore.
The promoters holding in the company stood at 70.40% while Non-Institutions held 29.60% of company’s stake.
Coral Laboratories has reported 70.45% rise in its net profit after tax at Rs 2.25 crore for second quarter ended September 30, 2013. as compared to Rs 1.32 crore for the same quarter in the previous year. Total income of the company has increased by 18.82% at Rs 12.37 crore for quarter under review as compared to Rs 10.41 crore for the quarter ended September 30, 2012.
Coral Laboratories is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1658.30 |
| Dr. Reddys Lab | 1218.90 |
| Cipla | 1230.95 |
| Zydus Lifesciences | 931.80 |
| Lupin | 2313.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: